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In the past few years numerous auto-immune
phenomena have been described in systemic
lupus erythematosus (SEE.). Reactions against
cellular components including whole nuclei
(1—3), nucleoprotein (2, 4), D.N.A. (5—7), histone
(3) as well as cytoplasmic elements (8, 9) have
been recorded. These reactions have been shown
to be mediated through serum antibodies.
Recently another auto-immune phenomenon
of a delayed hypersensitivity reaction against
intradermally injected white blood cells has been
described. Holman (10) found positive reactions
to a white cell homogenate injected into patients
with S.L.E.
Friedman, Bardawil, Merrill and Hanau (11)
tested 79 patients to either autologous or homol-
ogous whole leukocyte suspensions. They noted
that 16 of 20 patients with systemic lupus
erythematosus and 2 of 7 patients with
rheumatoid arthritis manifested positive reac-
tions. In their control group only 1 of 52 patients
manifested a positive test. Recently Bennett
and Holley (12) using homologous leukoeytes
have published results similar to those obtained
by Friedman et.al. (11) in S.L.E. The following
study was undertaken to evaluate the reaction to
intradermally injected autologous white blood
cells in patients having chronic discoid lupus
erythematosus (C.D.L.E.), other cutaneous
diseases and in healthy control subjects.
MATERIALS AND METHODS
Clinical Material
The subjects tested included 20 patients with
systemic L.E., 31 patients with typical chronic
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discoid hE., 9 patients with lymphoblastoma or
leukemia, 20 patients with atopy, (19 patients with
atopic dermatitis with or without associated
asthma and allergic rhinitis and 1 patient with
allergic rhinitis alone), 20 patients with mis-
cellaneous dermatologic conditions (psoriasis (1),
lichen planus (1), porphyria (2), alopecia areata
(1), lichen simplex chronicus (1), contact derma-
titis (3), male pattern alopecia (9) and poly-
morphous light eruptions (2). In additiou 10
normal volunteers, having no known disease,
served as a control group. The diagnosis in each
case was arrived at from both the clinical picture
presented at the time of testing and a careful
review of the patient's chart. Patients with L.E.
were classified as having the chronic discoid,
subacute, or acute varieties on the basis of the
skin lesions, history, laboratory findings and the
course of the disease.
The term C.D.L.E. in this study is used to
designate patients who displayed the classical
and purely cutaneous form of C.D.L.E., whether
localized (30 patients) or generalized (1 patient)
and who had a negative hE. cell preparation
and no consistent multisystem findings which
would suggest a diagnosis of systemic L.E. It
should be noted, however, that S of the 31 pa-
tients with C.D.L.E. did complain of arthralgias
and that 4 had elevated sedimentation rates.
Preparation of Test Materials
The materials for testing consisted of autol-
ogous 1) leukocyte suspension, 2) red blood cell
suspension, and 3) plasma.* The method reported
by Friedman et at. (11) was used as follows:
approximately 27.5 cc of venous blood are drawn
into a 30 ml glass syringe containing 10 mgm of
heparin and 400 mg of dextrant (2 cc of a 20%
aqueous autoclaved solution). The needle is then
occluded by insertion into an autoelaved cork and
the syringe placed in the refrigerator at 4° C in a
vertical position resting on the plunger. After 15
to 60 minutes in this position two distinct layers
appear—a lower layer of sedimented R.B.C. and
* Test materials also contained 0.03 mg heparin
and 1.3mg dextran per 0.1 ml plasma.
t Liquanemin Sodium, Organon Inc., Orange,N. J.
* Pharmachem Corp. (Formerly R. K. Laros
Co.) Bethlehem, Pa.
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an upper straw-colored layer of leukocytes and
platelets suspended in plasma. The upper straw-
colored layer is expressed into a centrifuge tube
by maintaining the syringe in vertical position,
applying pressure to the plunger and forcing the
fluid through the needle bent at a right angle.
Ten to 15 cc of straw-colored material usually
obtained by this procedure is then centrifuged at
approximately 2000 rpm for ten minutes in order
to separate the leukocytes. The plasma is pipetted
off until only a 1 cc volume remains in the tube.
The remaining plasma is then thoroughly mixed
with the leukocyte button to produce a homog-
enous leukocyte suspension. This constitutes the
leukocyte fraction. The cell free plasma is used
as the second test fraction and the sedimented red
blood cells which remain in the syringe constitute
the third test fraction.
In our studies, smears of the white blood cell
fraction showed white blood cells of both granulo-
cytic and lymphocytic series with a normal differ-
ential count and the presence of platelets. The
"contamination ratio" (number of W.B.C./num-
ber of R.B.C.) varied from 1:1 to 1:10. The leuko-
cyte fraction showed considerable variation in its
W.B.C. count per mm3, as was to be expected,
depending upon the W.B.C. count of the test
subject; the average count in this fraction was
65,000 W.B.C./mm3 and the range was 19,000 to
236,000 W.B.C./mm3. The amount of W.B.C.
used in the skin test showed no correlation with
the results obtained (see "Results").
Method of Skin Testing
Intradermal testing was done on the flexor
surface of the forearm with 0.1 cc of each of the
three test fractions. Tuberculin syringes and
2125 needles were used. The injections were made
immediately following preparation of the test
fractions and the sites were examined twenty-four
hours later.
A test was considered positive if an area of
induration greater than 10 mm associated with a
surrounding erythema was present. The average
positive test showed 16.8 mm of induration and
20.1 mm of erythema. A test was considered
negative if only erythema or induration less than
10 mm was present. The average negative test
measured 6 mm of combined induration and
erythema.
Positive reactions began to appear within 12—18
hours after injection, reached a maximum at 24
hours and at 48 hours were definitely diminishing.
At 72—96 hours the reaction had completely dis-
appeared. Histologically these positive white
blood cell test sites showed a banal perivascular
inflammatory infiltrate consisting mainly of
mononuclear cells with a small number of poly-
morphonuclear cells and histioeytes. No vascular
necrosis was seen. Bennett and Holley (12) who
have studied the histology of these reactions more
extensively stressed the mixture of mononuclear
and polymorphonuelear cells in the perivascular
infiltrate. In addition, by means of Masson's
triehrome and phosphotungstic aeid-hematoxylin
stains, they demonstrated a fibrinoid transudate
around blood vessels.
RESULTS
All tests performed with red blood cells and
plasma were negative except in one subject who
had seasonal allergic rhinitis at the time the
skin tests were done and who gave a positive
reaction to all three test materials. Three months
later he was retested and showed a positive test
to only the white blood cells. All other reactions
observed by us were to the white cells; therefore,
"positive test" as used hereafter refers to the
skin test with autologous white blood cells only.
Table 1 gives a summary of results obtained by
testing with autologous white blood cells.
Group I. Systemic L.E. There were 20 patients
in this group. Seventeen had acute systemic L.E.
at the time of the skin test. Sixteen of these 17
cases had a positive L.E. cell preparation. Skin
lesions were present in 12 of these 17 patients.
Five patients had no cutaneous lesions. The
lesions in 10 patients consisted of a butterfly
erythema sometimes associated with an
ephemeral patchy erythematous macular erup-
tion covered by fine scaling. Two patients had
lesions suggestive of a generalized discoid type;
TABLE 1
Results of intradermal W.B.C. skin tests
Number
of
coup Subjects
Tested
Number
Positive
to Skin
Test
Number
Negative
to Skin
Test
1*I. Systemic L.E
II. Chronic Discoid
20 19
L.E 31 10 21
III. Normal 10 0 10
IV. Lymphoblastoma-
Leukemia 9 4 5
V. Atopic disease.. ..
VI. Miscellaneous
20
20
5
3t
15
17
* This patient was in remission at the time of
the W.B.C. skin test.
t These 3 patients had a history of arthralgia.
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however, no definite atrophy was present. There
was no correlation between a positive white
blood cell skin test and the presence of skin
lesions or any particular type of skin lesions.
All 17 patients responded with a positive white
blood cell skin test. Two patients were considered
to have systemic L.E. of the subacute variety;
they had positive L.E. cell preparations but were
not acutely ill. Both showed positive W.B.C.
skin tests. One subject had a positive L.E. cell
preparation 3 months earlier but at the time of
skin testing was in apparent clinical remission
and on no medication. This patient had a negative
white blood cell skin test. Another patient in this
series who showed a positive W.B.C. skin test
while she was in an acute phase went into remis-
sion during chioroquine therapy. Subsequently
while her disease was in remission and at a time
when she no longer was taking chloroquine, her
white cell skin test was negative.
Group II. C.D.L.E. The 31 patients in this
group had the typical lesions and clinical course
of C.D.L.E. with no evidence of multi-system
involvement which would permit a diagnosis of
S.L.E. L.E. cell preparations were performed on
26 of these 31 patients and were negative. Ten
of these 31 patients had a positive white blood
skin test. L.E. cell preparations were performed
on 9 of these 10 positive reactors and were all
negative.
Group III. Normal control subjects. The 10
normal control subjects in this group were healthy
personnel working at the Skin and Cancer Unit
of University Hospital. No positive white blood
cell skin tests were elicited in any of these control
subjects.
Group IV. Leukemia—lymphoblastoma. Nine
patients in this group were diagnosed as having
leukemia or lymphoblastoma. Four of these
gave positive skin tests—2 had chronic lymphatic
leukemia, 1 had Hodgkin's sarcoma, and 1 had
stem cell leukemia. Negative white blood cell
skin tests were observed in one patient each with
Brill-Symmer's disease, Hodgkin's disease, malig—
nant lymphoma, monocytic leukemia and acute
myelogenous leukemia.
Group V. Atopic dermatitis and allergic
rhinitis. Of the 20 patients in this group, 4 out
of 19 having atopic dermatitis alone or in com-
bination with hay fever or asthma manifested
positive skin tests. In addition, one patient with
hay fever alone also showed a positive white
blood cell skin test.
Group VI. Miscellaneous dermatoses. A positive
white blood cell skin test was observed in 3 out
of the 20 cases with miscellaneous dermatologic
conditions (2 patients with male pattern alopecia
and one with a polymorphous light eruption.)
All 3, in addition to their dermatologic problem,
had arthralgias. An L.E. cell preparation could
be done only on one of these 3 patients and was
negative.
DIsCUssION
A hypersensitive reaction to intradermally
injected leukocyte suspension appears well
established in S.L.E. Friedman et al. (11) using
autologous and homologous leukocytes noted
positive findings in 16 of 20 S.L.E. patients.
Bennett and Holley (12), using a modified
technique, recently reported positive skin tests
in 15 of 17 patients with S.L.E. In our studies,
19 of 20 patients with S.L.E. manifested a
positive test.
It is interesting that the incidence of positive
skin tests in this series paralleled the severity
and acuteness of the disease process both in
terms of acute symptoms and in the severity of
the form of L.E. All S.L.E. patients in an active
phase were positive whereas patients who were in
remission and taking no medication gave nega-
tive tests. No direct relationship between posi-
tive skin test and organ systems involved by
disease could be found.
The nature of the antigen which is responsible
for the delayed intradermal reaction to autologous
W.B.C. has not yet been defined. Investigations
to characterize the antigen are currently in
progress.
The finding of 10 positive skin tests in 31
cases of classical chronic discoid L.E. may be
interpreted as another indication that C.D.L.E.
even when not accompanied by signs of systemic
involvement is, at least in some cases, part of
the same disease complex as S.L.E. Bennett
et al. (13) found 2 positive responses in 14 patients
with C.D.L.E. The difference between our results
may be due to their use of a slightly different
method for preparing the W.B.C fraction, to a
difference in criteria for classifying patients in the
various groups or to statistical factors inherent in
the small number of patients tested. Whether a
positive W.B.C. skin test in C.D.L.E. indicates
those patients who are particularly liable to
develop the subacute or acute form of L.E. later
on remains to be seen through long terms follow-
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up. No correlation could be found in C.D.L.E.
patients between a positive white blood cell
skin test and the duration or extent of disease,
presence of arthralgias, elevated sedimentation
rate, depressed or elevated white cell count,
differential count, hemoglobin, or urinary find-
ings. This appears to preclude the possibility
that leukopenia in S.L.E. is due to the same
factors which are responsible for the positive
skin reaction to W.B.C.
The strong possibility that this reaction is
mediated through a delayed type of hypersensi-
tivity mechanism is one of the most provocative
aspects of the W.B.C. skin test. Reports con-
cerning the immunology of L. E. have in the
past focused on serum antibodies. These have
been demonstrated against whole nuclei (1—3),
nueleoprotein (2, 4), D.N.A. (5—7), histone (3)
and eytoplasmie elements (8, 9); however, there
is no general agreement as to the importance
of these antibodies in the pathogenesis of L.E
It is tempting to speculate that the pathogenefie
changes seen in L.E. are the result of an auto-
sensitivity reaction mediated through cellular
and serum factors. This would explain why
during the first few months infants born of
mothers with acute L.E. do not develop manifes
tations of L.E. (14, 15) even though they may
have positive L.E. cell preparations. Apparently
a sufficient quantity of serum antibodies hut an
insufficient number of white blood cells nae
through the placental barrier.
The finding of positive skin tests in lympho-
blastoma and leukemia patients presents another
interesting problem. Others have reported posi
tive skin tests to lysed W.B.C. in acute leukemia
(16), and to cancer tissue in malignant melanoma.
(17) and various carcinomas (18). It is particu
larly noteworthy that the positive skin tests
occurred in our patients with leukemia or lyni-
phoblastoma involving stem cells or lymph
nodes. Does the positive test represent the
host's response against antigens in the malignant
cells or is this a phenomenon in which malignant,
yet immunologically competent cells are reacting
against the host's normal cellular constituents
in a manner similar to the reaction which pro-
duces "runt disease?" Further studies utilizing
passive transfer technic might produce a better
understanding of the nature of these reactions in
patients with leukemia and lyniphoblastoma.
The finding of positive skin tests in 5 of 20
patients with atopy also is noteworthy. Atopies
characteristically tend to have multiple allergic
responses of the immediate type to common
protein allergens. Whether these reactions against
white cells are due to inhaled or ingested protein
antigens phagoeytized by the white cells and
slowly released at the test site by the injected
leukoeytes or whether persons with a hereditary
atopie background tend to develop delayed
hypersensitivity to W.E.C. constituents or other
autologous materials cannot be answered at
this time.
The three positive responses occurring in con-
trol patients having arthralgias associated with
male pattern alopeeia and polymorphous light
eruption cannot be readily explained at present.
The fact that these 3 patients also had arthralgias
perhaps is of significance since Friedman et at.
(11) reported positive tests in 2 of 7 patients with
rheumatoid arthritis. Our 3 patients will be
followed clinically and with appropriate labora-
tory tests.
Our results make it obvious that the W.B.C.
skin test is not pathognomonie nor specific for
lupus erythematosus. It remains to be seen
whether a more specific skin test for L.E. can be
developed through the use of purified white
blood cell fractions. The significance of the
positive W.E.C. skin tests in eases of leukemia,
lymphoblastoma and atopy also requires further
investigation.
SUMMARY
Delayed cutaneous hypersensitivity to autolo-
gous leukoeytes was shown in 17 of 17 patients
with acute systemic L.E. 2 of 2 patients with
subacute L.E. and in 10 of 31 patients with
chronic discoid L.E. A negative test result was
obtained in 2 patients with S.L.E. in remission.
Positive tests were elicited also in three other
distinct groups: patients with leukemia or
lymphoma, patients with atopie dermatitis and
allergic rhinitis and patients with other
dermatoses.
Ten healthy control subjects gave negative
test results.
Evidence to date suggests that the skin reac-
tion to autologous W.B.C. represents a delayed
hypersensitivity response against leukoeytes
mediated through immunologically competent
cells rather than serum antibody. The possible
significance of positive skin tests to autologous
W.B.C. in L.E. and other diseases is discussed.
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DISCUSSION
DE. DONALD J. BLANEv (Cincinnati, Ohio):
When we read the initial report by Freidman
etat., we were impressed, and we did some
similar intradermal leukocyte tests, as did the
presenter. We came up with similar results,
some false-positives.
Since the antibodies that are present in the
circulating plasma in S.L.E., the gamma globulin
antibodies, are nonspecific insofar as they will
react with nucleo-protein from any source, it
seemed logical that the delayed type antibodies
might also be nonspecific and we could use
nucleoprotein from a more convenient source,
calf thymus, as an intradermal skin test.
If it would prove applicable, obviously it would
be very simple to have some lyophilized nucleo-
protein, just as we do tuberculin, and do skin
tests to screen for S.L.E.
So we tried it, and we came up with similar
results, that is, similar to testing with white
blood cells. We have seen false-positives just as
regularly and also false-negatives in some cases
of L.E. A generalized swelling rather than discrete
induration sometimes makes interpretation of
the test difficult.
Our series is not as extensive as the presenter's,
but I would say that in our hands the skin test
has not as yet been useful diagnostically; but
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it is interesting and perhaps explains some
manifestations of L.E. that are not explained by
serum antibodies.
DR. MARION B. SULZBERGER (New York,
New York): First of all, I want to say that this
is a very well presented piece of careful work and
I want to compliment Dr. Tromovitch and Dr.
March and coworkers on the great conservatism
which they have used in expressing and drawing
conclusions as to the mechanism and what the
results mean.
Then, I would like to hear tbeir comments
about the difference between this and the usual
delayed form of response. The early disappear-
ance of this reaction they have noted at a time
when the usual "delayed" form of skin response,
the tuberculin or, 48-hour-type of response is
just about reaching its maximum and beyond
which it then usually continues, points to some
difference here.
The second point I would like to make is that
if my figures arc correct (and I added up quickly
while listening to Dr. Tromovitch and looking
at the slide), and if you divide the series in the
following way: the lupus erythcmatosus acutus
or systemic lupus erythematosus cases in one
group and all the others as controls (that is the
blood dyscrasias, the atopic dermatitis, the
miscellaneous dermatoses and the normals) in
the other group, one finds that twenty-two out
of the ninety "controls" arc reacting to this skin
test with white cells—i.e. just about one-quarter
of all of the "controls" react.
To my mind this points up the fact that one
needs a great many more "normals" as controls
here to sec if the "normals" arc really non-reac-
tors in regard to this test and whether this 25%
incidence of reactors is not just the incidence of
positive reactions to leukocytes which will occur
in a general population which excludes acute
lupus erythematosus.
DR. ALEXANDER A. FISHER (Woodside, Long
Island, New York): I would like to know how
many immediate responses you had in your
series of "specific" cases or "unspecific" cases.
How did you decide that it is a delayed type
of reaction as we know eczcmatous or tuberculin?
Why couldn't it be an Arthus's phenomenon?
Did you make any biopsy studies to decide that
question.
DR. THEODORE A. TR0M0vITcH (in closing):
I with to thank the discussors for their comments.
In regard to Dr. Blaney's question, I prefer to
refer to these reactions not as false positives but
as positive reactions, which occur for reasons not
presently understood.
In viewing this data it is interesting to note
that these positive reactions tend to fall into
separate diagnostic groups and arc not randomly
distributed among all the disease states tested.
This was not completely predictable at the start
of this study.
I am very much interested in the skin test
reactions to nuclcoprotein, particularly the
source of the nucleoprotcin because Bennett and
Holley (Ref. 12) have used one type of nucleo-
protein and have not obtained positive skin
tests.
In a patient of Dr. Peter Miescher whole
nuclei from trophoblasts gave a negative skin
test even though she was positive to the white
blood cell skin test done at the same time.
In answer to Dr. Sulzbcrgcr's question regard-
ing the difference between this reaction pattern
and that of the tuberculin type, the former
probably fits best with what is called the inter-
mediate type or the so-called bacterial type of
hypersensitivity. This 24 hour type reaction is
seen as a response to bacterial antigens when used
to skin test patients sensitive to them.
As far as the validity of the test in each
category is concerned, I agree that the data
presented is insufficient from which to draw
definite conclusions. I think, however, that the
finding of positive skin tests in certain groups is
consistent with present knowledge. For example,
in the leukemia group one might expect to obtain
positive tests in the light of all the previous work
on other types of cancer where immunologic
responses have been shown against the neoplastic
tissue.
I believe it was Dr. Fisher who asked
about immediate responses. We did not tabulate
immediate responses because many times when
injecting simply serum, particularly into atopic
patients, a transient reaction would be seen.
We followed the delayed response which began
about 12 hours following the injection of the
test material.
In regard to biopsies, the microscopic picture
is not impressive, showing some perivascular
inflammatory infiltrate of lymphocytes, a few
histiocytes and a few polys.
Bennett and Holley reported that with
trichrome and phosphotungstic acid stains they
could demonstrate a transudate around blood
vessels which had a fibrinoid appearance.
